Stage-dependent prognostic shift in mismatch repair-deficient tumors: assessing patient outcomes in stage ii and iii colon cancer

HIGHLIGHTS

• who: Kjersti Elvestad Hestetun from the Ramón y Cajal University Hospital, Spain have published the paper: Stage-dependent prognostic shift in mismatch repair-deficient tumors: Assessing patient outcomes in stage II and III colon cancer, in the Journal: (JOURNAL)
• what: The aim of this study was to analyze the prognosis of dMMR stage III colon cancer and study the prognostic interplay between MMR status, tumor cell PD-L1 expression, and density of CD3+ and CD8+ lymphocytes. This study shows that the prognostic impact of dMMR depends on the stage. The authors propose that the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.